Innova Medical Group, Inc., yepasi rose yehutano yekuongorora uye yekuongorora innovator uye mugadziri mukuru pasi rose uye mugovani we lateral flow test kits, akasimbisa kuti kambani SARS-CoV-2 Antigen Tests inoona Omicron musiyano.
Kupindura kusimuka kwemusiyano uyu, matanho ehurumende akaunzwa svondo rino akadzoreredza kupfeka masiki muEngland muzvitoro nemuzvifambiso zveveruzhinji.
Nepo vaongorori vari kushanda nesimba kuona kushanda kwejekiseni uye zvinosimudzira kupesana nemusiyano mutsva, kuyedza nekukurumidza chinhu chakakosha mukudzora kupararira kwehutachiona nemazvo uye kubatsira kuchengetedza nharaunda. Innova yakasimbisa kuti Lateral Flow Tests yayo inoshanda pakutsvaga B.1.1.529 (Omicron) musiyano.
Innova akatanga kuongorora musiyano mushure mekuburitswa neWHO mukupera kwaMbudzi uye mhedzisiro yacho yakasimbiswa mune mamwe marabhoritari.
Zvidzidzo zvakawanda zvesainzi pamwe nekuongororwa kwehutano hweveruzhinji kwemamiriyoni evanhu nguva dzose zvakaratidza kukurumidza bvunzo dzeantigen chinhu chakakosha chekuziva vanhu vane hutachiona nekukurumidza uye zvakaenzana, kunyangwe kana vangave vasina zviratidzo zveCCIDID-19, nenzira i zviri nyore hazvigoneke nekunonoka, kudhura zvakanyanya, lab-based bvunzo. Izvi zvatonyanya kukosha zvichitevera mazano ekutanga Omicron akasiyana zviratidzo zvinogona kupfava mune vamwe vanhu pane mamwe madhirigi.
Nepo hutachiona huchiramba huchiita genetic ribonucleic acid ("RNA") kugadzira zvitsva uye zvinogona kutapurira zvakanyanya kana kukuvadza zvakanyanya, Innova's antigen test, iyo inoona mapuroteni akawanda muhutachiona, inogona kazhinji kuve chishandiso chinoshanda mukudzora kupararira. uye kuderedza kuvhiyiwa kupfuura dzimwe nzira, dzakadai sePCR yekuongorora.
Kana yakabatanidzwa nekuwedzera kwekugadzirwa kweInnova, kugona kwekuona kwakakura kweInnova's kukurumidza antigen bvunzo, iyo yakaparadzirwa zvakanyanya nehurumende kuUK yese mumhando dzakasiyana dzekushandisa kweanopfuura gore zvino, inotsikisa basa raInnova semudiwa akakosha. kumarudzi nemabhizinesi zvakafanana mukuve nemhando dzinopararira.
ZVOKUBVA MUNYAYA INO:
- Kana yakabatanidzwa nekuwedzera kwekugadzirwa kweInnova, kugona kwekuona kwakakura kweInnova's kukurumidza antigen bvunzo, iyo yakaparadzirwa zvakanyanya nehurumende kuUK yese mumhando dzakasiyana dzekushandisa kweanopfuura gore zvino, inotsikisa basa raInnova semudiwa akakosha. kumarudzi nemabhizinesi zvakafanana mukuve nemhando dzinopararira.
- Nepo hutachiona huchiramba huchiita genetic ribonucleic acid ("RNA") kugadzira zvitsva uye zvinogona kutapurira zvakanyanya kana kukuvadza zvakanyanya, Innova's antigen test, iyo inoona mapuroteni akawanda muhutachiona, inogona kazhinji kuve chishandiso chinoshanda mukudzora kupararira. uye kuderedza kuvhiyiwa kupfuura dzimwe nzira, dzakadai sePCR yekuongorora.
- Numerous scientific studies as well as ongoing public health screening of millions of people on a regular basis have shown rapid antigen tests are an important tool for identifying infectious people quickly and equitably, even when they may not have symptoms of COVID-19, in ways that simply are not possible with slower, more expensive, lab-based tests.
